| Views | |
|---|---|
| Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies | 331 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies | 0 | 4 | 3 | 0 | 12 | 12 | 5 |
| Views | |
|---|---|
| 2019_Diedrichs_etal.pdf | 263 |
